Rubedo Life Sciences, a biopharmaceutical company dedicated to developing advanced therapies targeting senescent cells linked to age-related diseases, has announced the opening of its European headquarters and clinical operations in Milan. This expansion precedes the company’s inaugural in-human Phase 1…
8×8, Inc. (NASDAQ: EGHT), a prominent provider of business communications, customer experience (CX), and CPaaS platforms, has announced that CareMonitor has successfully implemented 8×8 CPaaS to enhance critical patient interactions. The integration of 8×8 Jitsi as a Service (JaaS) and…
Modivcare Inc. (Nasdaq: MODV), a technology-enabled healthcare services company focused on improving health outcomes through integrated supportive care solutions, has successfully completed an 18-month Remote Patient Monitoring (RPM) pilot program. This initiative, conducted in collaboration with the Michigan Center for…
Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, has announced that the CDC’s Advisory Committee on Immunization Practices (ACIP) has voted to update the pneumococcal vaccination guidelines for adults. The committee recommends CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine)…
A recent study published in the Annals of Hepatology investigated the feasibility of using the AMRA® MAsS Scan, powered by the FDA-cleared AMRA® Profiler 4 device, to assess muscle composition in patients with end-stage liver disease (ESLD). This research is…
Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company known for its Invisalign® clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for restorative dentistry, has announced the launch of the latest version of its Invisalign Smile Architect…
This American Pharmacists Month, XiFin Pharmacy Solutions invites pharmacy professionals to join the 2025 Pharmacy Transformation Study, which aims to identify key success factors shaping the future of pharmacy care. With growing evidence of pharmacists’ positive impact on health outcomes,…
Spok, Inc., a subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a leader in healthcare communications, has published its 14th annual survey on communication practices within U.S. healthcare organizations. This survey assesses how clinical communication is managed, highlighting trends, challenges,…
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. have announced positive topline interim results from their ongoing Phase 3 clinical trial of sibeprenlimab for treating immunoglobulin A nephropathy (IgA nephropathy) in adults. Sibeprenlimab is an investigational anti-APRIL…
CEL-SCI Corporation (NYSE American: CVM) today highlighted the promising implications for its immunotherapy Multikine® (Leukocyte Interleukin, Injection) following a recent meeting of the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC), which serves as a public forum…
AMRA Medical, in collaboration with the University of Oslo, has published a study examining the effects of antidepressants (ADs), particularly serotonin-selective reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs), on muscle health and cardiometabolic risk. Conducted as part of the CoMorMent…
AptarGroup, Inc. (NYSE: ATR), a global leader in dosing, dispensing, and protection technologies for drug and consumer products, has announced the award of a contract from the U.S. Federal Government to further develop its ActivShield™ technology. This innovative solution enables…